POET Technologies: A $400 Million Cash Pile Meets a $503,000 Revenue Stream as Laser Shortage Fuels Ambition

The story at POET Technologies is one of staggering contrasts. The company has banked $400 million from a May capital raise, secured a partnership that could generate more than $500 million in revenue over five years, and plans to decuple its production capacity for optical engines by 2027. Yet its most recent quarterly revenue came in at just $503,000.

That revenue figure — more than double the year-ago level — underscores the gulf between ambition and execution that has left the stock swinging wildly. After hitting a 52-week high of €18.84 in mid-May, the shares have tumbled more than 56 percent. At last check, the stock traded at €8.56, a decline of roughly one-fifth over the preceding seven days, according to one source. Another data point puts the week’s closing price at €8.26, some 20 percent below the 50-day moving average of €10.40.

The volatility is extreme. Annualized 30-day volatility stands at nearly 128 percent, and the share price has seesawed enough to produce a year-to-date gain of about 40 percent by one measure — or 87 percent by another, depending on the reference point.

The laser bottleneck driving demand

The bull case hinges on a structural shortage in the optical components market. Three global laser suppliers control roughly 68 percent of the market, and all three are fully booked through the end of 2026. Earlier forecasts had expected relief by 2028, but POET’s management now sees the scarcity persisting until 2029.

That creates an opening. POET currently produces around 1 million optical engines annually. The projected demand for 800G and 1.6T engines alone is estimated at 1 million units per month by late 2027. The company intends to fill that gap by scaling up capacity tenfold.

A $50 million investment in new equipment, mostly in the second half of 2026, will underpin the expansion. Production is being built out in Penang, Malaysia, where POET has already begun wafer processing. The facility adds 20,000 square feet of assembly space to the company’s global footprint, which now includes more than 115 employees.

Should investors sell immediately? Or is it worth buying POET Technologies?

Partnerships, orders and a $500 million promise

The Lumilens agreement is the centerpiece of POET’s commercial trajectory. Signed in May, the deal includes an initial purchase order worth $50 million for optical engines and carries a cumulative volume target of more than $500 million over five years, provided the partnership scales as planned. The first end customer is described as a top-three hyperscaler.

Other revenue streams are emerging. POET has a production order from a system integrator worth more than $5 million for 800G engines. Ongoing projects with Adtran, NTT Innovative Devices, Lessengers and LITEON add further diversity.

Yet the revenue numbers remain tiny. In the first quarter of 2026, POET generated just $503,000 in sales. The net loss came in at $12.3 million, and operating cash flow was negative $8.8 million. The challenge is to convert signed agreements into shipped and invoiced products.

Cash in hand, legal clouds overhead

The $400 million capital raise, completed in May, provides ample runway. A single institutional investor subscribed for nearly 19 million new shares and a warrant for the same number. The proceeds are earmarked for manufacturing capacity, research and general operations.

That cash cushion is welcome, because a class-action lawsuit now hangs over the stock. The deadline for lead plaintiff applications expires today. The suit alleges false statements about the company’s tax status and a breach of a non-disclosure agreement by a manager in April 2026.

The legal overhang has not deterred the expansion plan. Penang ramps up in the second half of 2026, and the first delivery numbers will test whether the photonics promise can become a volume business. The difference between a $503,000 quarter and a $500 million partnership is the gap that POET now has to close.